<DOC>
	<DOC>NCT01828528</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of weight loss rate on liver steatosis, steatohepatitis, fibrosis and cardiovascular risk at different stages before and after bariatric surgery. The investigators also aim to study the short-term effect of bariatric surgery on gastric cholecystokinin levels before and 10 days after the bariatric surgery.</brief_summary>
	<brief_title>Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>20≤ age ≤80 BMI&gt;35kg/m2 Men and women Fatty infiltration in liver ultrasonography Alcohol drinking &gt; 140g/week Presence of hepatitis B or C or HIV Known liver disease such as: 1. Wilson's disease 2. hemochromatosis 3. α1antitrypsin deficiency 4. autoimmune liver disease 5. primary biliary cirrhosis 6. primary sclerosing cholangitis)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Nonalcoholic fatty liver disease</keyword>
	<keyword>Nonalcoholic steatohepatitis</keyword>
	<keyword>Obesity</keyword>
	<keyword>Bariatric surgery</keyword>
	<keyword>Weight loss</keyword>
</DOC>